- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2011 (2011), Article ID 294046, 5 pages
Analysis of the Pathogenesis of Experimental Autoimmune Optic Neuritis
Department of Ophthalmology, Tokyo Medical University, 6-7-1 Nishi-shinjuku, Shinjuku-ku, Tokyo 160-0023, Japan
Received 31 August 2010; Accepted 13 October 2010
Academic Editor: Oreste Gualillo
Copyright © 2011 Takeshi Kezuka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- V. A. Lennon, T. J. Kryzer, S. J. Pittock, A. S. Verkman, and S. R. Hinson, “IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel,” Journal of Experimental Medicine, vol. 202, no. 4, pp. 473–477, 2005.
- Y. Nakao, H. Yamamoto, E. Arimura et al., “Clinical features of anti-aquaporin 4 antibody-positive optic neuritis in Japanese,” Neuro-Ophthalmology Japan, vol. 25, no. 3, pp. 327–342, 2008.
- S. F. Roemer, J. E. Parisi, V. A. Lennon et al., “Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis,” Brain, vol. 130, no. 5, pp. 1194–1205, 2007.
- N. T. Potter and P. E. Bigazzi, “Acute optic neuritis associated with immunization with the CNS myelin proteolipid protein,” Investigative Ophthalmology and Visual Science, vol. 33, no. 5, pp. 1717–1722, 1992.
- M. K. Storch, A. Stefferl, U. Brehm et al., “Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology,” Brain Pathology, vol. 8, no. 4, pp. 681–694, 1998.
- H. Shao, Z. Huang, S. L. Sun, H. J. Kaplan, and D. Sun, “Myelin/oligodendrocyte glycoprotein-specific T-cells induce severe optic neuritis in the C57B1/6 mouse,” Investigative Ophthalmology and Visual Science, vol. 45, no. 11, pp. 4060–4065, 2004.
- E. Bettelli, M. Pagany, H. L. Weiner, C. Linington, R. A. Sobel, and V. K. Kuchroo, “Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis,” Journal of Experimental Medicine, vol. 197, no. 9, pp. 1073–1081, 2003.
- E. Bettelli, D. Baeten, A. Jäger, R. A. Sobel, and V. K. Kuchroo, “Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice,” Journal of Clinical Investigation, vol. 116, no. 9, pp. 2393–2402, 2006.
- N. Kaushansky, M.-C. Zhong, N. K. De Rosbo, R. Hoeftberger, H. Lassmann, and A. Ben-Nun, “Epitope specificity of autoreactive T and B cells associated with experimental autoimmune encephalomyelitis and optic neuritis induced by oligodendrocyte-specific protein in SJL/J mice,” Journal of Immunology, vol. 177, no. 10, pp. 7364–7376, 2006.
- K. C. O'Connor, K. A. McLaughlin, P. L. De Jager et al., “Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein,” Nature Medicine, vol. 13, no. 2, pp. 211–217, 2007.
- R. Meyer, R. Weissert, R. Diem et al., “Acute neuronal apoptosis in a rat model of multiple sclerosis,” Journal of Neuroscience, vol. 21, no. 16, pp. 6214–6220, 2001.
- Y. Guan, K. S. Shindler, P. Tabuena, and A. M. Rostami, “Retinal ganglion cell damage induced by spontaneous autoimmune optic neuritis in MOG-specific TCR transgenic mice,” Journal of Neuroimmunology, vol. 178, no. 1-2, pp. 40–48, 2006.
- M. B. Sättler, M. Togni, I. Gadjanski et al., “Strain-specific susceptibility for neurodegeneration in a rat model of autoimmune optic neuritis,” Journal of Neuroimmunology, vol. 193, no. 1-2, pp. 77–86, 2008.
- J. Guy, X. Qi, and W. W. Hauswirth, “Adeno-associated viral-mediated catalase expression suppresses optic neuritis in experimental allergic encephalomyelitis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 23, pp. 13847–13852, 1998.
- J. Guy, X. Qi, H. Wang, and W. W. Hauswirth, “Adenoviral gene therapy with catalase suppresses experimental optic neuritis,” Archives of Ophthalmology, vol. 117, no. 11, pp. 1533–1539, 1999.
- X. Qi, W. W. Hauswirth, and J. Guy, “Dual gene therapy with extracellular superoxide dismutase and catalase attenuates experimental optic neuritis,” Molecular Vision, vol. 13, pp. 1–11, 2007.
- X. Qi, L. Sun, A. S. Lewin, W. W. Hauswirth, and J. Guy, “Long-term suppression of neurodegeneration in chronic experimental optic neuritis: antioxidant gene therapy,” Investigative Ophthalmology and Visual Science, vol. 48, no. 12, pp. 5360–5370, 2007.
- X. Qi, A. S. Lewin, L. Sun, W. W. Hauswirth, and J. Guy, “Suppression of mitochondrial oxidative stress provides long-term neuroprotection in experimental optic neuritis,” Investigative Ophthalmology and Visual Science, vol. 48, no. 2, pp. 681–691, 2007.
- J. W. Streilein, “Ocular immune privilege: therapeutic opportunities from an experiment of nature,” Nature Reviews Immunology, vol. 3, no. 11, pp. 879–889, 2003.
- Y. Matsunaga, T. Kezuka, and Y. Usui, “Immune privilege ameliorates murine experimental autoimmune optic neuritis induced with myelin/oligodendrocyte glycoprotein,” in Proceedings of the Annual Meeting of Association for Research in Vision and Ophthalmology (ARVO '08), April 2008.